Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

11/5/25 8:35:00 AM ET

$BLTE

$COE

$HCM

$LOT

Biotechnology: Pharmaceutical Preparations

Health Care

Other Consumer Services

Real Estate

Get the next $BLTE alert in real time by email

NEW YORK, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the Depositary Receipts Virtual Investor Conference ("dbVIC") held November 4^th are now available for online viewing.

VIEW PRESENTATIONS HERE

The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company's resource section.

November 4^th Company Presentations

HUTCHMED (China) Limited	(AIM: HCM, NASDAQ:HCM, and HKEX:13)
First Pacific Company Ltd	((HKEX: 142, OTC:FPAFY)
Viomi Technology Co., Ltd	(NASDAQ:VIOT)
Epiroc AB	((Nasdaq Stockholm: EPIA, OTC:EPOAY)
Yiren Digital Ltd.	(NYSE:YRD)
Belite Bio, Inc	(NASDAQ:BLTE)
Deutsche Lufthansa AG	((FRA: LHA, OTCQX:DLAKY)
Lotus Technology Inc	(NASDAQ:LOT)
51Talk Online Education Group	(NYSE:COE)
Radiopharm Theranostics Ltd	(NASDAQ:RADX, ASX: RAD))
Repsol S.A	((BME: REP, OTCQX:REPYY)

To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

About Virtual Investor Conferences^®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

Media Contact:

OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com

Virtual Investor Conferences Contact:

John M. Viglotti

SVP Corporate Services, Investor Access

OTC Markets Group

(212) 220-2221

johnv@otcmarkets.com

Get the next $BLTE alert in real time by email

Recent Analyst Ratings for

Company	Date	Price Target	Rating	Analyst
Radiopharm Theranostics Limited $RADX	6/4/2026	$6.00	Buy	H.C. Wainwright
Belite Bio Inc $BLTE	1/26/2026	$195.00	Buy	BofA Securities
Belite Bio Inc $BLTE	1/6/2026	$191.00	Overweight	Morgan Stanley
Belite Bio Inc $BLTE	12/2/2025	$194.00	Neutral → Outperform	Mizuho
Belite Bio Inc $BLTE	11/24/2025	$154.00	Overweight	Cantor Fitzgerald
Belite Bio Inc $BLTE	11/20/2025	$105.00	Neutral	Mizuho
HUTCHMED (China) Limited $HCM	9/22/2025	$13.75	Equal-Weight → Underweight	Morgan Stanley
HUTCHMED (China) Limited $HCM	5/13/2025		Buy → Hold	HSBC Securities

More analyst ratings

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

11/5/25 8:35:00 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Other Consumer Services

Real Estate

Get the next $BLTE alert in real time by email

VIEW PRESENTATIONS HERE

The company presentations will be available 24/7 for 90 days. Investors, advisors, and analysts may download investor materials from the company's resource section.

November 4^th Company Presentations

HUTCHMED (China) Limited	(AIM: HCM, NASDAQ:HCM, and HKEX:13)
First Pacific Company Ltd	((HKEX: 142, OTC:FPAFY)
Viomi Technology Co., Ltd	(NASDAQ:VIOT)
Epiroc AB	((Nasdaq Stockholm: EPIA, OTC:EPOAY)
Yiren Digital Ltd.	(NYSE:YRD)
Belite Bio, Inc	(NASDAQ:BLTE)
Deutsche Lufthansa AG	((FRA: LHA, OTCQX:DLAKY)
Lotus Technology Inc	(NASDAQ:LOT)
51Talk Online Education Group	(NYSE:COE)
Radiopharm Theranostics Ltd	(NASDAQ:RADX, ASX: RAD))
Repsol S.A	((BME: REP, OTCQX:REPYY)

To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com.

Media Contact:

OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com

Virtual Investor Conferences Contact:

John M. Viglotti

SVP Corporate Services, Investor Access

OTC Markets Group

(212) 220-2221

johnv@otcmarkets.com

Get the next $BLTE alert in real time by email

Recent Analyst Ratings for

Company	Date	Price Target	Rating	Analyst
Radiopharm Theranostics Limited $RADX	6/4/2026	$6.00	Buy	H.C. Wainwright
Belite Bio Inc $BLTE	1/26/2026	$195.00	Buy	BofA Securities
Belite Bio Inc $BLTE	1/6/2026	$191.00	Overweight	Morgan Stanley
Belite Bio Inc $BLTE	12/2/2025	$194.00	Neutral → Outperform	Mizuho
Belite Bio Inc $BLTE	11/24/2025	$154.00	Overweight	Cantor Fitzgerald
Belite Bio Inc $BLTE	11/20/2025	$105.00	Neutral	Mizuho
HUTCHMED (China) Limited $HCM	9/22/2025	$13.75	Equal-Weight → Underweight	Morgan Stanley
HUTCHMED (China) Limited $HCM	5/13/2025		Buy → Hold	HSBC Securities

More analyst ratings

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$BLTE
$COE
$HCM
$LOT

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$BLTE
$COE
$HCM
$LOT

$BLTE
$COE
$HCM
$LOT
SEC Filings

SEC Form 6-K filed by Radiopharm Theranostics Limited

SEC Form F-3 filed by Viomi Technology Co. Ltd

SEC Form 6-K filed by Radiopharm Theranostics Limited

$BLTE
$COE
$HCM
$LOT
Press Releases

Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy

Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases

Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1

$BLTE
$COE
$HCM
$LOT
Analyst Ratings

H.C. Wainwright initiated coverage on Radiopharm Theranostics with a new price target

BofA Securities initiated coverage on Belite Bio with a new price target

Morgan Stanley initiated coverage on Belite Bio with a new price target

$BLTE
$COE
$HCM
$LOT
Insider Purchases

Director Shu Ting covered exercise/tax liability with 12,000 units of Class A Ordinary Share, bought 7,471,500 units of Class A Ordinary Share and converted options into 760,220 units of Class A Ordinary Share, increasing direct ownership by 14% to 493,620 units (SEC Form 4)

Chief Executive Officer Huang Jack Jiajia converted options into 72,720 units of Class A Ordinary Share, covered exercise/tax liability with 12,000 units of Class A Ordinary Share and bought $8,480,293 worth of Class A Ordinary Share (495,360 units at $17.12) (SEC Form 4)

Chief Executive Officer Huang Jack Jiajia bought $9,312,806 worth of Class A Ordinary Share (562,560 units at $16.55) (SEC Form 4)

$BLTE
$COE
$HCM
$LOT
Insider Trading

Director Lin Frank Hurst converted options into 72,720 units of Class A Ordinary Share, increasing direct ownership by 6% to 1,192,215 units (SEC Form 4)

Director Shu Ting covered exercise/tax liability with 12,000 units of Class A Ordinary Share, bought 7,471,500 units of Class A Ordinary Share and converted options into 760,220 units of Class A Ordinary Share, increasing direct ownership by 14% to 493,620 units (SEC Form 4)

Chief Executive Officer Huang Jack Jiajia converted options into 72,720 units of Class A Ordinary Share, covered exercise/tax liability with 12,000 units of Class A Ordinary Share and bought $8,480,293 worth of Class A Ordinary Share (495,360 units at $17.12) (SEC Form 4)

$BLTE
$COE
$HCM
$LOT
Leadership Updates

Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update

LOTUS Appoints Piano Master Lang Lang as Friend of the Brand

Viomi Technology Co., Ltd Appoints Malaysian Pop Star Shila Amzah as Brand Ambassador and Announces New AI Water Purifier Launch in Malaysia

$BLTE
$COE
$HCM
$LOT
Financials

Yiren Digital Reports First Quarter 2026 Unaudited Financial Results

Yiren Digital to Report First Quarter 2026 Financial Results on June 25, 2026

51Talk Online Education Group Announces First Quarter 2026 Results

$BLTE
$COE
$HCM
$LOT
Large Ownership Changes

Amendment: SEC Form SC 13D/A filed by 51Talk Online Education Group

Amendment: SEC Form SC 13G/A filed by Viomi Technology Co. Ltd

SEC Form SC 13G filed by Lotus Technology Inc.

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $BLTE$COE$HCM$LOT

Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for $BLTE$COE$HCM$LOT

$BLTE$COE$HCM$LOT SEC Filings

SEC Form 6-K filed by Radiopharm Theranostics Limited

SEC Form F-3 filed by Viomi Technology Co. Ltd

SEC Form 6-K filed by Radiopharm Theranostics Limited

$BLTE$COE$HCM$LOT Press Releases

Radiopharm Theranostics Achieves Confirmed Durable Partial Response in Ongoing Phase 1 Trial of RAD204 in Patients with Advanced Solid Tumors Post-Immunotherapy

Radiopharm Theranostics Announces Positive Phase 2b Trial Results of RAD 101 for Diagnosis of Brain Metastases

Belite Bio Announces Oral Presentation at the ASRS Annual Meeting Featuring Additional Positive Secondary Endpoint Data from the Phase 3 Trial of Tinlarebant in Stargardt Disease Type 1

$BLTE$COE$HCM$LOT Analyst Ratings

H.C. Wainwright initiated coverage on Radiopharm Theranostics with a new price target

BofA Securities initiated coverage on Belite Bio with a new price target

Morgan Stanley initiated coverage on Belite Bio with a new price target

$BLTE$COE$HCM$LOT Insider Purchases

Director Shu Ting covered exercise/tax liability with 12,000 units of Class A Ordinary Share, bought 7,471,500 units of Class A Ordinary Share and converted options into 760,220 units of Class A Ordinary Share, increasing direct ownership by 14% to 493,620 units (SEC Form 4)

Chief Executive Officer Huang Jack Jiajia converted options into 72,720 units of Class A Ordinary Share, covered exercise/tax liability with 12,000 units of Class A Ordinary Share and bought $8,480,293 worth of Class A Ordinary Share (495,360 units at $17.12) (SEC Form 4)

Chief Executive Officer Huang Jack Jiajia bought $9,312,806 worth of Class A Ordinary Share (562,560 units at $16.55) (SEC Form 4)

$BLTE$COE$HCM$LOT Insider Trading

Director Lin Frank Hurst converted options into 72,720 units of Class A Ordinary Share, increasing direct ownership by 6% to 1,192,215 units (SEC Form 4)

Director Shu Ting covered exercise/tax liability with 12,000 units of Class A Ordinary Share, bought 7,471,500 units of Class A Ordinary Share and converted options into 760,220 units of Class A Ordinary Share, increasing direct ownership by 14% to 493,620 units (SEC Form 4)

Chief Executive Officer Huang Jack Jiajia converted options into 72,720 units of Class A Ordinary Share, covered exercise/tax liability with 12,000 units of Class A Ordinary Share and bought $8,480,293 worth of Class A Ordinary Share (495,360 units at $17.12) (SEC Form 4)

$BLTE$COE$HCM$LOT Leadership Updates

Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate Update

LOTUS Appoints Piano Master Lang Lang as Friend of the Brand

Viomi Technology Co., Ltd Appoints Malaysian Pop Star Shila Amzah as Brand Ambassador and Announces New AI Water Purifier Launch in Malaysia

$BLTE$COE$HCM$LOT Financials

Yiren Digital Reports First Quarter 2026 Unaudited Financial Results

Yiren Digital to Report First Quarter 2026 Financial Results on June 25, 2026

51Talk Online Education Group Announces First Quarter 2026 Results

$BLTE$COE$HCM$LOT Large Ownership Changes

Amendment: SEC Form SC 13D/A filed by 51Talk Online Education Group

Amendment: SEC Form SC 13G/A filed by Viomi Technology Co. Ltd

SEC Form SC 13G filed by Lotus Technology Inc.

Recent Analyst Ratings for
$BLTE
$COE
$HCM
$LOT

Recent Analyst Ratings for
$BLTE
$COE
$HCM
$LOT

$BLTE
$COE
$HCM
$LOT
SEC Filings

$BLTE
$COE
$HCM
$LOT
Press Releases

$BLTE
$COE
$HCM
$LOT
Analyst Ratings

$BLTE
$COE
$HCM
$LOT
Insider Purchases

$BLTE
$COE
$HCM
$LOT
Insider Trading

$BLTE
$COE
$HCM
$LOT
Leadership Updates

$BLTE
$COE
$HCM
$LOT
Financials

$BLTE
$COE
$HCM
$LOT
Large Ownership Changes